Taming systems to create enabling environments for HCV treatment: Negotiating trust in the drug and alcohol setting

Social Science and Medicine

Volumn 83, Issue , 2013, Pages 19-26

  Harris, Magdalena ^a   Rhodes, Tim ^a   Martin, Anthea ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Drug and alcohol services; Enabling environments; Hepatitis C; People who inject drugs; Treatment; Trust; United Kingdom

Indexed keywords

DISEASE TREATMENT; DRUG; HEALTH CARE; HEALTH SERVICES; HEPATITIS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE ACCESS; HEALTH EDUCATION; HELP SEEKING BEHAVIOR; HEPATITIS C; HUMAN; MALE; PATIENT CARE; QUALITATIVE RESEARCH; THEMATIC ANALYSIS; TREATMENT INDICATION; UNITED KINGDOM;

ADULT; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C; HUMANS; LONDON; MALE; MIDDLE AGED; NEGOTIATING; PROFESSIONAL-PATIENT RELATIONS; QUALITATIVE RESEARCH; QUALITY OF HEALTH CARE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; TRUST;

ENGLAND; LONDON [ENGLAND]; UNITED KINGDOM;

HEPATITIS C VIRUS;

EID: 84875392958     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2013.01.031     Document Type: Article

References (35)

1. Barbour R. The biographical turn and the 'socialization' of medicine. Medical Sociology Online 2011, 6(1):15-25.
2. Bourgois P., Schonberg J. Righteous dopefiend 2009, University of California Press, Los Angeles.
3. Canfield K., Smyth E., Batki S. Methadone maintenance patients' knowledge, attitudes, beliefs, and experiences concerning treatment for HCV infection. Substance Use & Misuse 2010, 45(4):496-514.
4. Carr G. Negotiating trust: a grounded theory study of interpersonal relationships between persons living with HIV/AIDS and their primary health care providers. Journal of the Association of Nurses in AIDS Care 2001, 12(2):35-43.
5. Davies H. Falling public trust in health services: Implications for accountability. Journal of Health Services Research & Policy 1999, 4(4):193-194.
6. Fraser S., valentine k Substance and substitution: Methadone subjects in liberal societies 2008, Palgrave Macmillan, New York.
7. Ghany M., Strader B., Thomas D., Seeff L. Diagnosis, management and treatment of HCV: an update. Hepatology 2009, 49(4):1335-1374.
8. Giddens A. The consequences of modernity 1990, Polity Press, Cambridge.
9. Gilson L. Trust and the development of health care as a social institution. Social Science & Medicine 2003, 56(7):1453-1468.
10. Harris M., Rhodes T. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs. Addiction 2012, 107:1090-1096.
11. Harris M., Rhodes T. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'. International Journal of Drug Policy 2012, 10.1016/j.drugpo.2012.10.003.
12. Harris, M. & Rhodes, T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduction Journal, submitted for publication.
13. Jauffret-Roustide M., Cohen J., Poisot-Martin I., Spire B., Gossop M., Carrieri M. Distributive sharing among HIV-HCV co-infected injecting drug users: the preventive role of trust in one's physician. AIDS Care 2012, 24(2):232-238.
14. Kirst M. Social capital and beyond. Journal of Drug Issues 2009, 39(3):653-676.
15. Lally M., Montstream-Quas S., Tanaka S., Tedeschi S., Morrow K. A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care & STDs 2008, 22(1):53-64.
16. Latour B. Reassembling the social 2005, Oxford University Press, Oxford.
17. Lazarus J., Shete P., Eramova I., Merkinaite S., Matic S. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management. International Journal of Drug Policy 2007, 18(5):426-432.
18. Luhmann N. Trust and power 1979, John Wiley and Sons, Brisbane.
19. Ly K., Xing J., Klevens R., Jiles R., Ward J., Holmberg S. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Annals of Internal Medicine 2012, 156(4):271-278.
20. Martin N., Vickerman P., Foster G., Hutchinson S., Goldberg D., Hickman M. Can antiviral therapy for HCV reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility. Journal of Hepatology 2011, 54(6):1137-1144.
21. Meyer S., Ward P. Reworking the sociology of trust: Making a semantic distinction between trust and dependence. The Australian Sociological Association 2009 Annual Conference 2009, ANU, Canberra.
22. Neale J. Homelessness, drug use and hepatitis C: a complex problem explored within the context of social exclusion. International Journal of Drug Policy 2008, 19(6):429-435.
23. Osilla K., Ryan G., Bhatti L., Goetz M., Witt M., Wagner G. Factors that influence an HIV coinfected patient's decision to start hepatitis C treatment. AIDS Patient Care and STDs 2009, 23(12):993-999.
24. Ostertag S., Wright B., Broadhead R., Altice F. Trust and other characteristics associated with health care utilization by injection drug users. Journal of Drug Issues 2006, 36(4):953-974.
25. Palmateer N., Kimber J., Hickman M., Hutchinson S., Rhodes T., Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing HCV and HIV transmission among injecting drug users: a review of reviews. Addiction 2010, 105:844-859.
26. Paterson B., Backmund M., Hirsch G., Yim C. The depiction of stigmatization in research about hepatitis C. International Journal of Drug Policy 2007, 18(5):364-373.
27. Rance J., Newland J., Hopwood M., Treloar C. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics. Social Science & Medicine 2012, 74(2):245-253.
28. Rhodes T., Harris M., Martin M. Negotiating access to medical treatment and the making of patient citizenship: the case of hepatitis C treatment. Sociology of Health and Illness 2013, 10.1111/1467-9566.12018.
29. Rhodes T., Prodanović A., Žikić B., Kuneski E., Pavićević T., KaradŽić D., et al. Trust, disruption and responsibility in accounts of injecting equipment sharing and hepatitis C risk. Health, Risk & Society 2008, 10(3):221-240.
30. Swan D., Long J., Carr O., Flanagan J., Irish H., Keating S., et al. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. AIDS Patient Care & STDs 2010, 24(12):753-762.
31. Thom D., Campbell B. Patient-physician trust: an exploratory study. The Journal of Family Practice 1997, 44(2):169-176.
32. Treloar C., Fraser S. Hepatitis C treatment in pharmacotherapy services: Increasing treatment uptake needs a critical view. Drug and Alcohol Review 2009, 28:436-440.
33. Treloar C., Holt M. Drug treatment clients' readiness for hepatitis C treatment: implications for expanding treatment services in drug and alcohol settings. Australian Health Review 2008, 32(3):570.
34. Treloar C., Newland J., Rance J., Hopwood M. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. Journal of Viral Hepatitis 2010, 17(12):839-844.
35. World Health Organisation Hepatitis C facts and figures 2011, Retrieved 08 March 2011 from. http://www.euro.who.int/en/what-we-do/health-topics/communicable-diseases/hepatitis/facts-and-figures/hepatitis-c.